P3 Health reaffirms 2022 guidance, sees 2023 revenue $1.2B-$1.25B, narrower EBITDA loss

P3 Health Partners Inc.

Reaffirmed FY2022 revenue $1.025B-$1.075B (61-69% YoY growth); at-risk MA membership >100k.
FY2023 guidance: revenue $1.20B-$1.25B, membership 115k-120k, Adj. EBITDA loss $40M-$60M.
Company anticipates achieving positive Adj. EBITDA in 2024.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

P3 Health Partners Inc. updated its full-year 2022 guidance (reaffirmed).

Period: full-year 2022
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

P3 is reaffirming full-year 2022 financial guidance

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

P3 Health Partners Inc. updated its full-year 2022 guidance (reaffirmed).

Period: full-year 2022
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

P3 is reaffirming the revenue guidance range given on the third quarter earnings call of between $1.025 billion and $1.075 billion

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

P3 Health Partners Inc. updated its full-year 2023 guidance (initiated).

Period: full-year 2023
Guidance: initiated
Result: guidance update

Exact text from the filing

announcing financial guidance for the full-year 2023

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

P3 Health Partners Inc. updated its full-year 2023 guidance (initiated).

Period: full-year 2023
Guidance: initiated
Result: guidance update

Exact text from the filing

Revenue is expected to be in a range of $1.20 billion to $1.25 billion

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-003071

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.